1 / 9

Molecular Diagnostics Market to grow at 8.1% CAGR from 2016 to 2023

Get more details @ http://bit.ly/2oUDIou <br>Key industry players include Abbott Laboratories, Alere, Becton Dickinson, Bayer Healthcare, Bio-Rad Laboratories, Dako, bioMerieux, Cepheid, Hologic (Gen Probe), Danaher Corporation, Novartis (Grifols), Siemens Healthcare, Roche Diagnostics, Johnson & Johnson, Qiagen, and Sysmex Corporation.

jueekate
Download Presentation

Molecular Diagnostics Market to grow at 8.1% CAGR from 2016 to 2023

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Molecular Diagnostics Market to see growth of 8.1% from 2016 to 2023:Global Market Insights Inc. Fuel Cell Market size worth $25.5bn by 2024

  2. Key Insights from Molecular Diagnostics Market : • Rampant use of advanced PoC (point of care) diagnostics devices across the healthcare sector will spur molecular diagnostics market growth. • Furthermore, heavy demand for personalized drugs as well as companion diagnostics along with high expenditure on activities pertaining to medical diagnostics clinical research will drive the market trends over the coming six years. • DNA/RNA Purification, PCR (Polymerase chain reaction), and Real-Time PCR are some of the key molecular diagnostics technologies. • Real time PCR is also expected to make substantial contributions towards molecular diagnostics market size, driven by breakthroughs in clinical microbiology, molecular biology, and instrumentation. • Contagious diseases such as tuberculosis, hepatitis C, flu, RSV (Respiratory syncytial virus), meningitis, hepatitis B, HPV (human papillomavirus), Dengue, and STD (Sexually Transmitted Disease) are projected to contribute significantly towards molecular diagnostics market revenue over the next few years.

  3. Continued... • HPV is anticipated to nurture molecular diagnostics industry growth over 2016-2023. Rise in HPV infections across the globe is expected to drive the growth. • APAC molecular diagnostics industry size is expected to grow considerably over the coming timeframe. • Rise in incidence of contagious diseases as well HAIs (hospital acquired infections), high patient population base, fast economic development, and preventive healthcare legislations will be the key driving factors. • Large acceptance of modern technologies along with high investments across the healthcare sector to improve the care services is expected to accelerate Europe molecular diagnostics industry growth. • Key industry participants include Johnson & Johnson, bioMerieux, Becton Dickinson, Abbott Laboratories, Danaher Corporation, Cepheid, Bio-Rad Laboratories, Bayer Healthcare, F. Hoffmann-La Roche AG, Siemens Healthcare, Dako, and Novartis.

  4. Germany Molecular diagnostics market size, by technology, 2012-2023 (USD Million)

  5. Table of Content: Chapter 1. Methodology and Scope 1.1. Research Methodology 1.1.1. Initial data exploration 1.1.2. Statistical model and forecast 1.1.3. Industry insights and validation 1.1.4. Research scope and assumptions 1.2. Data Sources 1.2.1. Primary sources 1.2.2. Secondary sources Chapter 2. Executive Summary 2.1. Molecular Diagnostics industry 3600 synopsis, 2012 - 2023 2.1.1. Business trends 2.1.2. Disease trends 2.1.3. Technological trends 2.1.4. Regional trends

  6. Table of Content: Chapter 3. Molecular Diagnostics Market Industry Insights 3.1. Industry segmentation 3.2. Industry size and forecast, 2012 - 2023 3.3. Industry impact forces 3.3.1. Growth drivers 3.3.1.1. Technological advancements 3.3.1.2. Growing POC demand 3.3.1.3. Increasing geriatric population 3.3.1.4. Considerable R&D initiatives 3.3.2. Industry pitfalls & challenges 3.3.2.1. Unclear regulatory landscape 3.3.2.2. Cost concerns

  7. Table of Content: 3.4. Growth potential analysis 3.5. Regional opportunities 3.6. Disease type opportunities 3.7. Porter’s analysis 3.8. PESTEL analysis 3.9. Company market share analysis, 2015 3.9.1. Key product landscape 3.9.2. Competitive landscape

  8. Browse Full Market Research Report On Molecular Diagnostics Market @ http://bit.ly/2oUDIou Request for a Sample of this Research Report @ https://www.gminsights.com/request-sample/detail/434

  9. Stay In Touch Website: www.gminsights.com Social Media:

More Related